MedPath

Micrima Ltd.

Micrima Ltd. logo
🇬🇧United Kingdom
Ownership
Holding
Established
2005-01-01
Employees
11
Market Cap
-
Website
http://www.micrima.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Micrima MARIA Data Collection for Machine Learning Study

Not Applicable
Conditions
Breast Cancer
First Posted Date
2021-05-20
Last Posted Date
2022-05-20
Lead Sponsor
Micrima, Ltd.
Target Recruit Count
400
Registration Number
NCT04894955
Locations
🇬🇧

Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

The ABC Study: Assessment of Breast Density Classification

Not Applicable
Conditions
Breast Cancer
First Posted Date
2021-05-11
Last Posted Date
2022-05-20
Lead Sponsor
Micrima, Ltd.
Target Recruit Count
800
Registration Number
NCT04882306
Locations
🇬🇧

North Devon Breast Screening Service- In Health, Exeter, United Kingdom

M5 vs. M6 Comparison Study With a Sub Study Into the Dielectric Constant of Aspirated Cyst Fluid

Not Applicable
Completed
Conditions
Breast Cyst
Breast Cancer Female
First Posted Date
2018-12-11
Last Posted Date
2020-02-20
Lead Sponsor
Micrima, Ltd.
Target Recruit Count
22
Registration Number
NCT03771833
Locations
🇬🇧

Thirlestaine Breast Centre, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, United Kingdom

Synthetic Aperture Radar Detection of Breast Tumours

Completed
Conditions
Mammogram Scheduled
First Posted Date
2015-07-09
Last Posted Date
2018-08-17
Lead Sponsor
Micrima, Ltd.
Target Recruit Count
264
Registration Number
NCT02493595
Locations
🇬🇧

North Bristol Trust NHS Breast Care Clinic, Bristol, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.